![](gfx/trans.png)
![Ascending Ascending](gfx/order_arrow_asc.png) Symbol
|
![](gfx/trans.png)
![](gfx/order_arrow.png) HGNC ID
|
![](gfx/trans.png)
![](gfx/order_arrow.png) Gene
|
![](gfx/trans.png)
![](gfx/order_arrow.png) Chr
|
![](gfx/trans.png) Band
|
![](gfx/trans.png)
![](gfx/order_arrow.png) Transcripts
|
![](gfx/trans.png)
![](gfx/order_arrow.png) Variants
|
![](gfx/trans.png)
![](gfx/order_arrow.png) Unique variants
|
![](gfx/trans.png)
![](gfx/order_arrow.png) Last updated
|
![](gfx/trans.png) Associated with diseases
|
A1BG |
HGNC:5 |
alpha-1-B glycoprotein |
19 |
q13.43 |
1 |
11 |
5 |
2022-01-23 |
- |
A1BG-AS1 |
HGNC:37133 |
A1BG antisense RNA 1 |
19 |
q13.4 |
1 |
- |
- |
N/A |
- |
A1CF |
HGNC:24086 |
APOBEC1 complementation factor |
10 |
q21.1 |
2 |
1 |
1 |
2024-02-26 |
- |
A2LD1 |
HGNC:25100 |
AIG2-like domain 1 |
13 |
q32.3 |
1 |
75 |
56 |
2024-04-19 |
- |
A2M |
HGNC:7 |
alpha-2-macroglobulin |
12 |
p13.31 |
1 |
8 |
7 |
2023-01-11 |
AD, alpha-2-macroglobulin deficiency |
A2M-AS1 |
HGNC:27057 |
A2M antisense RNA 1 |
12 |
p13.31 |
1 |
- |
- |
N/A |
- |
A2ML1 |
HGNC:23336 |
alpha-2-macroglobulin-like 1 |
12 |
p13 |
1 |
177 |
121 |
2024-04-19 |
OMS |
A2MP1 |
HGNC:8 |
alpha-2-macroglobulin pseudogene 1 |
12 |
p13.31 |
1 |
- |
- |
2018-11-03 |
- |
A3GALT2 |
HGNC:30005 |
alpha 1,3-galactosyltransferase 2 |
1 |
p35.1 |
1 |
- |
- |
2019-12-04 |
- |
A4GALT |
HGNC:18149 |
alpha 1,4-galactosyltransferase |
22 |
q13.2 |
1 |
2 |
2 |
2023-01-11 |
blood group P |
A4GNT |
HGNC:17968 |
alpha-1,4-N-acetylglucosaminyltransferase |
3 |
p14.3 |
1 |
1 |
1 |
2020-06-15 |
- |
AAAS |
HGNC:13666 |
achalasia, adrenocortical insufficiency, alacrimia |
12 |
q13 |
1 |
42 |
31 |
2024-04-19 |
AAAS, ID |
AACS |
HGNC:21298 |
acetoacetyl-CoA synthetase |
12 |
q24.31 |
1 |
5 |
5 |
2022-05-09 |
- |
AACSP1 |
HGNC:18226 |
acetoacetyl-CoA synthetase pseudogene 1 |
5 |
q35 |
1 |
- |
- |
N/A |
- |
AADAC |
HGNC:17 |
arylacetamide deacetylase |
3 |
q25.1 |
1 |
1 |
1 |
2020-06-15 |
- |
AADACL2 |
HGNC:24427 |
arylacetamide deacetylase-like 2 |
3 |
q25.1 |
1 |
- |
- |
N/A |
- |
AADACL3 |
HGNC:32037 |
arylacetamide deacetylase-like 3 |
1 |
p36.21 |
2 |
1 |
1 |
2020-06-03 |
- |
AADACL4 |
HGNC:32038 |
arylacetamide deacetylase-like 4 |
1 |
p36.21 |
1 |
- |
- |
N/A |
- |
AADAT |
HGNC:17929 |
aminoadipate aminotransferase |
4 |
q33 |
1 |
- |
- |
N/A |
- |
AAED1 |
HGNC:16881 |
AhpC/TSA antioxidant enzyme domain containing 1 |
9 |
q22.32 |
1 |
1 |
1 |
N/A |
- |
AAGAB |
HGNC:25662 |
alpha- and gamma-adaptin binding protein |
15 |
q22.33-q23 |
1 |
9 |
7 |
N/A |
PPKP1A |
AAK1 |
HGNC:19679 |
AP2 associated kinase 1 |
2 |
p13.3 |
1 |
4 |
4 |
2024-02-26 |
- |
AAMDC |
HGNC:30205 |
adipogenesis associated, Mth938 domain containing |
11 |
q14.1 |
1 |
2 |
2 |
2020-07-01 |
- |
AAMP |
HGNC:18 |
angio-associated, migratory cell protein |
2 |
q |
1 |
11 |
10 |
2022-05-09 |
- |
AANAT |
HGNC:19 |
aralkylamine N-acetyltransferase |
17 |
q25 |
1 |
20 |
13 |
2024-04-19 |
DSPS |
AAR2 |
HGNC:15886 |
AAR2 splicing factor homolog |
20 |
q11.23 |
1 |
1 |
1 |
2021-09-17 |
- |
AARD |
HGNC:33842 |
alanine and arginine rich domain containing protein |
8 |
q24.11 |
1 |
1 |
1 |
2024-04-19 |
- |
AARS |
HGNC:20 |
alanyl-tRNA synthetase |
16 |
q22 |
1 |
188 |
94 |
2024-04-29 |
CMT2N, DEE29 |
AARS2 |
HGNC:21022 |
alanyl-tRNA synthetase 2, mitochondrial |
6 |
p21.1 |
1 |
89 |
62 |
2024-04-19 |
COXPD8, ID, LKENP |
AARSD1 |
HGNC:28417 |
alanyl-tRNA synthetase domain containing 1 |
17 |
q21.31 |
1 |
18 |
11 |
2020-07-13 |
- |
AASDH |
HGNC:23993 |
aminoadipate-semialdehyde dehydrogenase |
4 |
q12 |
1 |
1 |
1 |
2021-09-17 |
- |
AASDHPPT |
HGNC:14235 |
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase |
11 |
q22 |
1 |
- |
- |
2022-09-15 |
- |
AASS |
HGNC:17366 |
aminoadipate-semialdehyde synthase |
7 |
q31.3 |
1 |
23 |
21 |
2024-04-19 |
Hyperlysinemia, saccharopinuria |
AATF |
HGNC:19235 |
apoptosis antagonizing transcription factor |
17 |
q12 |
1 |
1 |
1 |
2020-07-13 |
- |
AATK |
HGNC:21 |
apoptosis-associated tyrosine kinase |
17 |
q25.3 |
1 |
8 |
8 |
2020-09-15 |
- |
AATK-AS1 |
HGNC:40053 |
AATK antisense RNA 1 |
17 |
q25.3 |
1 |
- |
- |
N/A |
- |
ABAT |
HGNC:23 |
4-aminobutyrate aminotransferase |
16 |
p13.2 |
1 |
23 |
19 |
2024-04-19 |
Gamma-aminobutyric acid transaminase deficiency |
ABCA1 |
HGNC:29 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
9 |
q31 |
1 |
1091 |
871 |
2024-05-31 |
FH, HDLCD2, TGD |
ABCA10 |
HGNC:30 |
ATP-binding cassette, sub-family A (ABC1), member 10 |
17 |
q24 |
1 |
8 |
8 |
2024-04-19 |
- |
ABCA11P |
HGNC:31 |
ATP-binding cassette, sub-family A (ABC1), member 11, pseudogene |
4 |
p16.3 |
1 |
13 |
13 |
2020-08-06 |
- |
ABCA12 |
HGNC:14637 |
ATP-binding cassette, sub-family A (ABC1), member 12 |
2 |
q34 |
1 |
149 |
111 |
2024-02-26 |
ARCI4A, ARCI4B |
ABCA13 |
HGNC:14638 |
ATP-binding cassette, sub-family A (ABC1), member 13 |
7 |
p12.3 |
1 |
114 |
68 |
2024-04-19 |
- |
ABCA17P |
HGNC:32972 |
ATP-binding cassette, sub-family A (ABC1), member 17, pseudogene |
16 |
p13.3 |
1 |
- |
- |
N/A |
- |
ABCA2 |
HGNC:32 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
9 |
q34 |
1 |
40 |
36 |
2024-04-19 |
IDPOGSA |
ABCA3 |
HGNC:33 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
16 |
p13.3 |
1 |
50 |
40 |
2024-02-26 |
SMDP3 |
ABCA4 |
HGNC:34 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
1 |
p22 |
1 |
34513 |
2792 |
2024-05-31 |
ARMD, ARMD2, CORD3, RP19, STGD1 |
ABCA5 |
HGNC:35 |
ATP-binding cassette, sub-family A (ABC1), member 5 |
17 |
q24.3 |
1 |
14 |
10 |
2024-04-19 |
HTC3 |
ABCA6 |
HGNC:36 |
ATP-binding cassette, sub-family A (ABC1), member 6 |
17 |
q21 |
1 |
5 |
5 |
2022-05-09 |
- |
ABCA7 |
HGNC:37 |
ATP-binding cassette, sub-family A (ABC1), member 7 |
19 |
p13.3 |
1 |
35 |
34 |
2024-04-19 |
AD9 |
ABCA8 |
HGNC:38 |
ATP-binding cassette, sub-family A (ABC1), member 8 |
17 |
q24 |
1 |
2 |
2 |
2020-07-14 |
- |
ABCA9 |
HGNC:39 |
ATP-binding cassette, sub-family A (ABC1), member 9 |
17 |
q24 |
1 |
1 |
1 |
2020-07-14 |
- |
ABCB1 |
HGNC:40 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
7 |
q21.12 |
2 |
16 |
14 |
2024-04-19 |
CLCS, IBD13 |
ABCB10 |
HGNC:41 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
1 |
q32 |
1 |
- |
- |
N/A |
- |
ABCB11 |
HGNC:42 |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
2 |
q24 |
1 |
120 |
89 |
2024-03-27 |
BRIC2, PFIC, PFIC2 |
ABCB4 |
HGNC:45 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
7 |
q21 |
2 |
114 |
86 |
2024-05-13 |
GBD1;LPAC, ICP3, PFIC, PFIC3 |
ABCB5 |
HGNC:46 |
ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
7 |
p14 |
1 |
4 |
4 |
2021-01-22 |
- |
ABCB6 |
HGNC:47 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
2 |
q36 |
1 |
83 |
64 |
2024-02-26 |
DUH3, LAN, MCOPCB7, PSHK2 |
ABCB7 |
HGNC:48 |
ATP-binding cassette, sub-family B (MDR/TAP), member 7 |
X |
q13.3 |
1 |
51 |
33 |
2024-04-19 |
ASAT |
ABCB8 |
HGNC:49 |
ATP-binding cassette, sub-family B (MDR/TAP), member 8 |
7 |
q36.1 |
1 |
7 |
7 |
2020-09-15 |
- |
ABCB9 |
HGNC:50 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
12 |
q24 |
1 |
- |
- |
2019-12-04 |
- |
ABCC1 |
HGNC:51 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
16 |
p13.1 |
1 |
27 |
27 |
2024-04-19 |
- |
ABCC10 |
HGNC:52 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 10 |
6 |
p12.3 |
1 |
9 |
8 |
2024-02-09 |
- |
ABCC11 |
HGNC:14639 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 11 |
16 |
q12 |
1 |
120 |
7 |
2021-09-29 |
ear wax dry |
ABCC12 |
HGNC:14640 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 12 |
16 |
q12.1 |
1 |
6 |
4 |
2021-02-08 |
- |
ABCC13 |
HGNC:16022 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 13, pseudogene |
21 |
q11.2 |
1 |
- |
- |
N/A |
- |
ABCC2 |
HGNC:53 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
10 |
q24 |
1 |
64 |
50 |
2023-01-11 |
DJS |
ABCC3 |
HGNC:54 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
17 |
q21 |
1 |
5 |
4 |
2024-04-19 |
- |
ABCC4 |
HGNC:55 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
13 |
q31 |
1 |
10 |
10 |
2020-07-04 |
- |
ABCC5 |
HGNC:56 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
3 |
q27 |
1 |
4 |
4 |
2020-06-16 |
- |
ABCC5-AS1 |
HGNC:40055 |
ABCC5 antisense RNA 1 |
3 |
q27.1 |
1 |
- |
- |
N/A |
- |
ABCC6 |
HGNC:57 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
16 |
p13.11 |
1 |
1733 |
572 |
2024-04-23 |
GACI2, PXE, PXEFF |
ABCC6P1 |
HGNC:33352 |
ATP-binding cassette, sub-family C, member 6 pseudogene 1 |
16 |
p12.3 |
1 |
- |
- |
N/A |
- |
ABCC6P2 |
HGNC:33353 |
ATP-binding cassette, sub-family C, member 6 pseudogene 2 |
16 |
p13.11 |
1 |
1 |
1 |
N/A |
- |
ABCC8 |
HGNC:59 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
11 |
p15.1 |
1 |
565 |
503 |
2024-04-19 |
HHF1, LIH, NIDDM, PNDM3, TNDM, TNDM2 |
ABCC9 |
HGNC:60 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
12 |
p12.1 |
1 |
459 |
261 |
2024-04-19 |
ATFB12, Cantu, CMD1O, IDMYS |
ABCD1 |
HGNC:61 |
ATP-binding cassette, sub-family D (ALD), member 1 |
X |
q28 |
1 |
266 |
184 |
2024-04-22 |
ALD, ID |
ABCD2 |
HGNC:66 |
ATP-binding cassette, sub-family D (ALD), member 2 |
12 |
q12 |
1 |
1 |
1 |
N/A |
- |
ABCD3 |
HGNC:67 |
ATP-binding cassette, sub-family D (ALD), member 3 |
1 |
p21.3 |
1 |
3 |
3 |
2024-02-26 |
CBAS5, hepatosplenomegaly |
ABCD4 |
HGNC:68 |
ATP-binding cassette, sub-family D (ALD), member 4 |
14 |
q24 |
1 |
37 |
28 |
2024-04-19 |
ID, MAHCJ |
ABCE1 |
HGNC:69 |
ATP-binding cassette, sub-family E (OABP), member 1 |
4 |
q31 |
1 |
- |
- |
2019-12-04 |
- |
ABCF1 |
HGNC:70 |
ATP-binding cassette, sub-family F (GCN20), member 1 |
6 |
p21.33 |
1 |
1 |
1 |
2020-06-18 |
- |
ABCF2 |
HGNC:71 |
ATP-binding cassette, sub-family F (GCN20), member 2 |
7 |
q36.1 |
1 |
3 |
3 |
2020-06-23 |
- |
ABCF3 |
HGNC:72 |
ATP-binding cassette, sub-family F (GCN20), member 3 |
3 |
q27.1 |
1 |
3 |
3 |
2023-01-11 |
- |
ABCG1 |
HGNC:73 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
21 |
q22.3 |
1 |
- |
- |
2024-04-19 |
- |
ABCG2 |
HGNC:74 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
4 |
q22.1 |
1 |
12 |
10 |
2022-10-14 |
JR, UAQTL1 |
ABCG4 |
HGNC:13884 |
ATP-binding cassette, sub-family G (WHITE), member 4 |
11 |
q23 |
1 |
- |
- |
N/A |
- |
ABCG5 |
HGNC:13886 |
ATP-binding cassette, sub-family G (WHITE), member 5 |
2 |
p21 |
1 |
399 |
354 |
2024-02-26 |
STSL, STSL2 |
ABCG8 |
HGNC:13887 |
ATP-binding cassette, sub-family G (WHITE), member 8 |
2 |
p21 |
1 |
462 |
410 |
2024-02-26 |
GDB4, STSL, STSL1 |
ABHD1 |
HGNC:17553 |
abhydrolase domain containing 1 |
2 |
p23.3 |
1 |
3 |
3 |
2024-01-23 |
- |
ABHD10 |
HGNC:25656 |
abhydrolase domain containing 10 |
3 |
q13.2 |
1 |
3 |
3 |
2020-08-06 |
- |
ABHD11 |
HGNC:16407 |
abhydrolase domain containing 11 |
7 |
q11.23 |
2 |
- |
- |
N/A |
- |
ABHD11-AS1 |
HGNC:18289 |
ABHD11 antisense RNA 1 (tail to tail) |
7 |
q11.23 |
1 |
- |
- |
N/A |
- |
ABHD12 |
HGNC:15868 |
abhydrolase domain containing 12 |
20 |
p11.21 |
1 |
166 |
100 |
2024-04-19 |
PHARC |
ABHD12B |
HGNC:19837 |
abhydrolase domain containing 12B |
14 |
q21.3 |
1 |
3 |
3 |
2024-04-19 |
- |
ABHD13 |
HGNC:20293 |
abhydrolase domain containing 13 |
13 |
q33.2 |
1 |
- |
- |
N/A |
- |
ABHD14A |
HGNC:24538 |
abhydrolase domain containing 14A |
3 |
p21.1 |
1 |
21 |
18 |
2024-04-19 |
- |
ABHD14A-ACY1 |
HGNC:38856 |
ABHD14A-ACY1 readthrough (non-protein coding) |
3 |
p21.2 |
1 |
18 |
15 |
2024-04-19 |
- |
ABHD14B |
HGNC:28235 |
abhydrolase domain containing 14B |
3 |
p21.2 |
1 |
5 |
4 |
2024-04-19 |
- |
ABHD15 |
HGNC:26971 |
abhydrolase domain containing 15 |
17 |
q11.2 |
1 |
1 |
1 |
2020-07-13 |
- |
ABHD16A |
HGNC:13921 |
abhydrolase domain containing 16A |
6 |
p21.3 |
1 |
13 |
7 |
2022-05-09 |
- |